European Medicines Agency and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) sign cooperation agreement
NewsMedicines
14/06/2010 - The new arrangement between the two agencies furthers cooperation and boosts exchange of information and expertise on psychoactive substances. The EMCDDA will report on an ad hoc basis to the EMA on any misuse of medicinal products detected through its networks, complementing information gathered through the EU pharmacovigilance system. The EMA will be able to provide ad hoc reports to the EMCDDA on the misuse of authorised medicinal products.